Home/ Supplements/ Melatonin/ Melatonin 3 mg

Melatonin 3 mg

product on market Tablet or Pill AvPak Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Melatonin is a hormone that regulates sleep-wake cycles and is used to reduce sleep onset latency. There is strong evidence supporting its efficacy for short-term sleep disturbances and jet lag. This formulation is generally well-tolerated and considered safe for most adults.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Melatonin 3 mg
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Tablet(s)
Serving Size
50
Servings
Non-Nutrient/Non-Botanical
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

3 mg
Market median: 3.0mg (984 products) 240 studies (A:2, B:109)

Other Ingredients

Calcium Carbonate Microcrystalline Cellulose Maltodextrin Acacia Croscarmellose Sodium Magnesium Stearate Silica Stearic Acid
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Directions for Use

Directions: As a dietary supplement, take one tablet 20 to 30 minutes before bedtime.

Warnings & Precautions

Do not take more than two tablets daily unless advised by your health care professional.

Warning: Use only at bedtime, for adult use only.

Not for use by children, teenagers, pregnant or lactating women.

Not for use by children, teenagers, pregnant or lactating women. If you are under medical supervision, have a autoimmune disease, diabetes, a depression disorder, epilepsy, leukemia or a lymphoproliferative disorder or are taking monoamine oxidase inhibitor drugs or corticosteroids such as cortisone or prednisone, consult with your physician before taking this product.

Keep out of the reach of children.

Formulation Notes

Preservative and gluten free, no sugar, starch, artificial colors, artificial flavors, wheat, yeast or corn added.

Additional Information

NDC 50268-524-15

Guaranteed Release Lab Tested Potency Assay

50 tablets (5 X 10) unit dose

This product is manufactured under strict quality control guidelines; therefore, purity and label potency are guaranteed.

Store in a cool, dry place.

USA Mfg. formula 610

A product of AvKare

AV 04/13 (P)

Metadata

Product Details

UPC / SKU5026852415
DSLD Entry Date2018-07-25
Product TypeNon-Nutrient/Non-Botanical
FormTablet or Pill
BrandAvPak
DSLD ID178870
Data Updated2026-04-11
Research

Research Evidence

291
Research Sources
55
Avg Quality
129
Meta Analysis
93
Systematic Review
51
Rct
11
Clinical Trial
2
Other
2
Regulatory Source
1
Openfda Safety
A Interventions for preventing delirium in hospitalised non-ICU patients
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Melatonin for preoperative and postoperative anxiety in adults
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Effect of melatonin on quality of life and symptoms in patients with cancer: a systematic review and meta-analysis of randomised controlled trials
Meta Analysis BMJ open 2022 PubMed DOI
B Pharmacological interventions for prevention of weight gain in people with schizophrenia
Meta Analysis The Cochrane database of systematic reviews 2022 PubMed DOI
B Melatonin for pre- and postoperative anxiety in adults
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
B Prevention of depression in adults with long-term physical conditions
Meta Analysis The Cochrane database of systematic reviews 2021 PubMed DOI
B Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis
Systematic Review Lancet (London, England) 2022 PubMed DOI
B Does melatonin administration reduce the incidence of postoperative delirium in adults? Systematic review and meta-analysis
Meta Analysis BMJ open 2023 PubMed DOI
B Second-generation antidepressants for preventing seasonal affective disorder in adults
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
B Interventions for preventing type 2 diabetes in adults with mental disorders in low- and middle-income countries
Meta Analysis The Cochrane database of systematic reviews 2021 PubMed DOI
View all evidence for Melatonin →
Compare

Similar Products

View all Melatonin products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.